Advertisement
Singapore markets closed

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    5,003.49
    -68.14 (-1.34%)
     

  • Dow

    37,889.05
    -571.87 (-1.49%)
     

  • Nasdaq

    15,420.53
    -292.22 (-1.86%)
     

  • Bitcoin USD

    63,301.16
    -2,805.39 (-4.24%)
     

  • CMC Crypto 200

    1,364.08
    -18.49 (-1.34%)
     

  • FTSE 100

    8,054.20
    +13.82 (+0.17%)
     

  • Gold

    2,332.80
    -5.60 (-0.24%)
     

  • Crude Oil

    82.63
    -0.18 (-0.22%)
     

  • 10-Yr Bond

    4.7310
    +0.0790 (+1.70%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Why AbbVie and Amgen Are Moving Lower Today

George Budwell, The Motley Fool
·2-min read
Why AbbVie and Amgen Are Moving Lower Today

Shares of the immunology juggernaut AbbVie (NYSE: ABBV) were down by 4% on sky-high volume as of 11 a.m. ET Thursday. The big loss came after Coherus Biosciences announced a partnership with billionaire Mark Cuban's pharmaceuticals start-up -- known as the Mark Cuban Cost Plus Drug Company -- to sell a biosimilar (a generic biologic) version of AbbVie's flagship anti-inflammatory medication, Humira, at an 85% discount. Coherus' biosimilar will be branded as Yusimry.

Continue reading